{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:22:11Z","timestamp":1783196531290,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1447700"],"award-info":[{"award-number":["21ZR1447700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2017-24-2301"],"award-info":[{"award-number":["Z-2017-24-2301"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.intimp.2025.116050","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:01:14Z","timestamp":1766124074000},"page":"116050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Melittin-loaded solid lipid nanoparticles inhibit pulmonary fibrosis via the NOVA2-TGF-\u03b2\/Smads signaling pathway"],"prefix":"10.1016","volume":"170","author":[{"given":"Xinghua","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.116050_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2025.116050_bb0010","article-title":"Manual therapy as an alternative treatment option for idiopathic pulmonary fibrosis: a case report","volume":"16","author":"Greenberg","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2025.116050_bb0015","first-page":"1","article-title":"Computational and in vitro screening validates the repositioning potential of Coxibs as anti-fibrotic agents","author":"Karande","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.intimp.2025.116050_bb0020","first-page":"11","article-title":"High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis. BMJ open","author":"Miura","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2025.116050_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/5573353","article-title":"Qingfei Tongluo mixture attenuates bleomycin-induced pulmonary inflammation and fibrosis through mTOR-dependent autophagy in rats","volume":"2024","author":"Ge","year":"2024","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2025.116050_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.14715\/cmb\/2024.70.2.18","article-title":"Astragaloside IV inhibits idiopathic pulmonary fibrosis through activation of autophagy by miR-21-mediated PTEN\/PI3K\/AKT\/mTOR pathway","volume":"70","author":"Li","year":"2024","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"key":"10.1016\/j.intimp.2025.116050_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117893","article-title":"Anti-fibrotic effect of melittin on TRIM47 expression in human embryonic lung fibroblast through regulating TRIM47 pathway","volume":"256","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.116050_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091137","article-title":"The protective effect of Melittin on renal fibrosis in an animal model of unilateral ureteral obstruction","volume":"21","author":"An","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.116050_bb0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1258\/ebm.2011.011127","article-title":"Melittin attenuates liver injury in thioacetamide-treated mice through modulating inflammation and fibrogenesis","volume":"236","author":"Park","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2025.116050_bb0050","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/nn400683s","article-title":"Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo","volume":"7","author":"Huang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.116050_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","article-title":"Solid lipid nanoparticles: a review on recent perspectives and patents","volume":"30","author":"Paliwal","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.intimp.2025.116050_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.intimp.2025.116050_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123644","article-title":"Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models","volume":"649","author":"Kaur","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2025.116050_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2014.06.055","article-title":"Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors","volume":"192","author":"Nafee","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.116050_bb0075","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12951-023-02223-4","article-title":"Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies","volume":"21","author":"Yu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2025.116050_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12951-023-02026-7","article-title":"Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles","volume":"21","author":"Dai","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2025.116050_bb0085","first-page":"4875","article-title":"Co-delivery of EGCG and melittin with self-assembled fluoro-nanoparticles for enhanced cancer therapy","volume":"15","author":"Sun","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.intimp.2025.116050_bb0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-023-03449-7","article-title":"Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2","volume":"14","author":"Liu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2025.116050_bb0095","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1002\/jcb.28612","article-title":"Chemokine (C-X-C motif) ligand 14 contributes to lipopolysaccharide-induced fibrogenesis in mouse L929 fibroblasts via modulating PPM1A","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.116050_bb0100","article-title":"RNA-binding proteins as therapeutic targets in cardiac fibrosis and heart failure","author":"Gotthardt","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2025.116050_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00018-025-05673-1","article-title":"m6A reader IGF2BP1 facilitates macrophage glycolytic metabolism and fibrotic phenotype by stabilizing THBS1 mRNA to promote pulmonary fibrosis","volume":"82","author":"Hu","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2025.116050_bb0110","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/1759-7714.15141","article-title":"Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR-330-5p","volume":"14","author":"Xia","year":"2023","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.intimp.2025.116050_bb0115","first-page":"7","article-title":"METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2-dependent mechanism","author":"Hou","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.intimp.2025.116050_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202102912","article-title":"Neutrophil decoys with anti-inflammatory and anti-oxidative properties reduce secondary spinal cord injury and improve neurological functional recovery","volume":"31","author":"Bi","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.intimp.2025.116050_bb0125","first-page":"17","article-title":"Formulation and comparative characterization of SLNs and NLCs for targeted co-delivery of paclitaxel and Hydroxytyrosol carboxylic acid esters against triple-negative breast Cancer","author":"Peira","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.116050_bb0130","first-page":"5","article-title":"Fibulin-1c regulates transforming growth factor-\u03b2 activation in pulmonary tissue fibrosis","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.116050_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2025.116050_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12320","article-title":"Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor \u03b2 cytokine blocking the TGF\u03b2RI\/TGF\u03b2RII receptor complex-pilot study","volume":"14","author":"Mateusz","year":"2024","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.intimp.2025.116050_bb0145","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.2147\/IJN.S453347","article-title":"Development of curcumin and Turmerone loaded solid lipid nanoparticle for topical delivery: optimization, characterization and skin irritation evaluation with 3D tissue model","volume":"19","author":"Aydin","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2025.116050_bb0150","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.2147\/IJN.S532246","article-title":"Advances in lipid-based nanomedicine: pathway specific siRNA therapy and optimizing delivery for hepatocellular carcinoma","volume":"20","author":"Thalij","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2025.116050_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.intimp.2025.116050_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2006.12.002","article-title":"Nanotechnology platforms and physiological challenges for cancer therapeutics","volume":"3","author":"Kim","year":"2007","journal-title":"Nanomedicine"},{"key":"10.1016\/j.intimp.2025.116050_bb0165","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.msec.2016.09.016","article-title":"Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: a too simplistic explanation that does not take into account the nanoparticle protein corona","volume":"70","author":"Forest","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.intimp.2025.116050_bb0170","first-page":"12","article-title":"Melittin-based Nano-delivery systems for Cancer therapy","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2025.116050_bb0175","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1529\/biophysj.108.130559","article-title":"Melittin-lipid bilayer interactions and the role of cholesterol","volume":"95","author":"Wessman","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.intimp.2025.116050_bb0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcis.2010.02.032","article-title":"Effect of \u03b1-helical peptides on liposome structure: a comparative study of melittin and alamethicin","volume":"346","author":"Wessman","year":"2010","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.intimp.2025.116050_bb0185","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1002\/adma.201300638","article-title":"Surface functionalization of gold nanoparticles with red blood cell membranes","volume":"25","author":"Gao","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2025.116050_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nnano.2017.47","article-title":"Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes","volume":"12","author":"Wibroe","year":"2017","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.intimp.2025.116050_bb0195","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.116050_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117371","article-title":"Targeted counteracting of overactive macrophages by melittin stable-loaded solid lipid nanoparticles alleviates cytokine storm and acute inflammatory injury","volume":"179","author":"Zheng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.116050_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28227508","article-title":"Sulconazole-loaded solid lipid nanoparticles for enhanced antifungal activity: in vitro and in vivo approach","volume":"28","author":"Samee","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.116050_bb0210","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1039\/D1FO04212B","article-title":"Antifibrotic effect of AD-1 on lipopolysaccharide-mediated fibroblast injury in L929 cells and bleomycin-induced pulmonary fibrosis in mice","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2025.116050_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114405","article-title":"N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2\/3","volume":"160","author":"Nakamura","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.116050_bb0220","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1096\/fj.201901291RRRRR","article-title":"8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2\/3 and interacting with Smad7","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2025.116050_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6268091","article-title":"Influence of silica exposure for lung silicosis rat","volume":"2021","author":"Jiao","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2025.116050_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154030","article-title":"Protective effect and mechanism of loganin and morroniside on acute lung injury and pulmonary fibrosis","volume":"99","author":"Chen","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.116050_bb0235","article-title":"circELP2 reverse-splicing biogenesis and function as a pro-fibrogenic factor by targeting mitochondrial quality control pathway","volume":"28","author":"Zhang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.116050_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00997294","article-title":"Comparative studies of native and synthetic melittins","volume":"270","author":"Habermann","year":"1971","journal-title":"Naunyn Schmiedebergs Arch. Pharmakol."},{"key":"10.1016\/j.intimp.2025.116050_bb0245","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219432","article-title":"M6P-modified solid lipid nanoparticles loaded with matrine for the treatment of fibrotic liver","volume":"30","author":"Tan","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.intimp.2025.116050_bb0250","article-title":"Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats","volume":"17","author":"Silva","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2025.116050_bb0255","doi-asserted-by":"crossref","DOI":"10.1177\/09603271231200213","article-title":"TLR4\/ MyD88\/NF-\u03baB signaling pathway involved in the protective effect of diacerein against lung fibrosis in rats","volume":"42","author":"Abdel-Aziz","year":"2023","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.intimp.2025.116050_bb0260","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1007\/s10753-023-01877-4","article-title":"Incomplete knockdown of MyD88 inhibits LPS-induced lung injury and lung fibrosis in a mouse model","volume":"46","author":"Fan","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2025.116050_bb0265","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.2147\/OTT.S171678","article-title":"Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature","volume":"11","author":"Gallo","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.intimp.2025.116050_bb0270","first-page":"L667","article-title":"Endothelial cell interactions with immune cells and fibroblasts in the pulmonary microenvironment: from the developing to the aging lung Sientific session III ReSPIRE 2025","volume":"329","author":"Caporarello","year":"2025","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.intimp.2025.116050_bb0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15476286.2020.1734372","article-title":"Identification of NOVA family proteins as novel \u03b2-catenin RNA-binding proteins that promote epithelial-mesenchymal transition","volume":"17","author":"Tang","year":"2020","journal-title":"RNA Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925020399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:10:59Z","timestamp":1777619459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925020399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":55,"alternative-id":["S1567576925020399"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116050","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melittin-loaded solid lipid nanoparticles inhibit pulmonary fibrosis via the NOVA2-TGF-\u03b2\/Smads signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.116050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116050"}}